眼眶横纹肌肉瘤多模式治疗后残留眶内肿物的频率与临床病程
回顾性分析4个美国中心1998-2019年32例原发性眼眶横纹肌肉瘤患者,均接受化疗和放疗。残留肿物可自行消失、稳定或需切除,1例进展行眶内容剜除。12周完全缓解与治疗结束完全缓解相关(P < .001)。
要点
- 多模式治疗后约三分之一患者影像上存在残留眶内肿物。
- 残留肿物可自行消失(4、32、53个月)、稳定或需手术切除。
- 12周完全缓解与治疗结束完全缓解显著相关(P < .001)。
核心结论
- 多模式治疗后约三分之一患者影像上可见残留眶内肿物,其转归从数月到数年不等,可自行消失、稳定或需切除。
研究设计与样本
- 回顾性病例系列,纳入4个美国中心1998-2019年接受化疗和放疗的原发性眼眶横纹肌肉瘤患者32例。
主要发现
- 32例中男性22例,小于18岁30例;组织学亚型为胚胎型22例、腺泡型8例、混合胚胎/腺泡型2例。
- 中位随访46个月(范围4.9-199个月),2例死亡。
- 12周完全缓解与治疗结束完全缓解相关(P < .001)。
- 初诊T1或T2肿瘤患者末次随访完全缓解率高于T3或T4患者(P < .05);活检类型(切开或切除)与任何时间点治疗反应无关。
临床怎么用
- 对多模式治疗后的眼眶横纹肌肉瘤患者,影像上残留肿物并不罕见,需结合临床和影像随访观察,避免不必要的活检或切除。
局限性
- 回顾性设计,样本量较小(32例),部分患者缺乏可靠治疗结束影像。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the frequency and clinical course of residual orbital masses on imaging studies after multimodality treatment for orbital rhabdomyosarcoma. DESIGN: Retrospective case series. METHODS: We reviewed records of patients with primary orbital rhabdomyosarcoma who underwent chemotherapy and radiotherapy after surgical biopsy or debulking at 4 US centers during 1998-2019. Demographics, histologic subtype, tumor response 12 weeks after chemotherapy initiation and after completion of all treatment, and imaging findings were analyzed. RESULTS: Thirty-two patients met inclusion criteria. Twenty-two were male, and 30 were younger than 18 years. Histologic subtype was embryonal in 22 patients, alveolar in 8, and mixed embryonal/alveolar in 2. Median follow-up time was 46 months (range, 4.9-199 months). Two patients died. Twenty-seven patients had reliable end-of-treatment imaging findings, of whom 9 had a residual mass. Three residual masses disappeared spontaneously (by 4, 32, and 53 months), 2 remained at last contact, at 2 and 7 years of follow-up, and 3 were excised; 1 progressed and underwent an exenteration. Complete response at 12 weeks was associated with complete response at the end of treatment (P < .001). Patients with T1 or T2 tumor at presentation were more likely to have complete response at last contact than were those with T3 or T4 tumor (P < .05). Biopsy type (incisional or excisional) was not associated with response to treatment at any time point. CONCLUSION: A residual orbital mass on imaging may be present after multimodality treatment in approximately one-third of patients. Resolution without biopsy or excision varied from months to years.
引用
- Sobel RK, Ford JR, Dong W, et al. Frequency and Clinical Course of Residual Orbital Masses After Treatment of Orbital Rhabdomyosarcoma. Am J Ophthalmol. 2021. PMID: 34280364. doi:10.1016/j.ajo.2021.06.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。